Cambridge
Cambridge ECMC aims to develop molecular prognostic and diagnostic tests to aid treatment decisions. The Centre focuses on genetic predisposition to cancer and the identification of high risk groups. This is being achieved by building on local strengths in genomics, pharmacogenetics, molecular pathology, molecular imaging, clinical informatics and computational biology.
Clinical Focus Area
- Early phase trials and experimental therapeutics
- Surgical oncology
- Cancer imaging
- Biomarkers
- Screening
- Neoadjuvant therapy
- Brain metastasis
Scientific Focus Area
- Cancer genomics and molecular stratification
- Chemical biology and medicinal chemistry
- Cancer stem cells
- Hormone receptor (AR/ER) regulation
- Pre-clinical imaging
- Pre-clinical drug development
- Germline genetic variation
Disease Focus
| Brain | Breast | Kidney | Leukaemia |
| Liver | Lung | Non-Hodgkins Lymphoma | Oesophageal |
| Ovarian | Pancreatic | Prostate | Sarcoma |
Goals
Skills
Cambridge ECMC principal investigators and staff have a range of skills and expertise.
Facilities
Cambridge ECMC has access to a range of research facilities that are utilised in studies.
Increase text
Decrease text
Print this page